Inventor · disambiguated record
Ningxin Yan
Also filed as: YAN NINGXIN
24 granted patents·13 pending applications·140 citations·filing 2015–2024
95Inventor score
Files withINSYS DEV CO INC13HIKMA PHARMACEUTICALS USA INC12RADIUS PHARMACEUTICALS INC8INSYS PHARMA INC2HOFFMANN LA ROCHE1
Top patents by PatentIndex Score
37 records- 0197US11628139B2Liquid naloxone sprayHIKMA PHARMACEUTICALS USA INC·Filed 2021·Granted Apr 18, 2023·7 cites·12 claims
- 0296US11617713B2Liquid naloxone sprayHIKMA PHARMACEUTICALS USA INC·Filed 2021·Granted Apr 4, 2023·4 cites·18 claims
- 0396US11135155B2Liquid naloxone sprayHIKMA PHARMACEUTICALS USA INC·Filed 2018·Granted Oct 5, 2021·8 cites·19 claims
- 0496US10441538B2Liquid naloxone sprayINSYS DEV CO INC·Filed 2018·Granted Oct 15, 2019·16 cites·10 claims
- 0596US10039710B2Epinephrine spray formulationsINSYS DEV CO INC·Filed 2017·Granted Aug 7, 2018·27 cites·27 claims
- 0695US11975096B2Liquid naloxone sprayHIKMA PHARMACEUTICALS USA INC·Filed 2021·Granted May 7, 2024·2 cites·19 claims
- 0795US10973814B2Liquid naloxone sprayHIKMA PHARMACEUTICALS USA INC·Filed 2019·Granted Apr 13, 2021·10 cites·12 claims
- 0894US10722510B2Liquid naloxone sprayINSYS DEV CO INC·Filed 2016·Granted Jul 28, 2020·10 cites·7 claims
- 0994US10617686B2Liquid naloxone sprayINSYS DEV CO INC·Filed 2017·Granted Apr 14, 2020·13 cites·5 claims
- 1093US11331279B2Stable cannabinoid formulationsRADIUS PHARMACEUTICALS INC·Filed 2015·Granted May 17, 2022·11 cites·8 claims
- 1193US9642848B2Sublingual naloxone sprayINSYS PHARMA INC·Filed 2015·Granted May 9, 2017·25 cites·6 claims
- 1289US11224660B2Stable cannabinoid formulationsRADIUS PHARMACEUTICALS INC·Filed 2015·Granted Jan 18, 2022·4 cites·12 claims
- 1384US12414915B2Liquid naloxone sprayHIKMA PHARMACEUTICALS USA INC·Filed 2023·Granted Sep 16, 2025·0 cites·1 claims
- 1484US11571384B2Epinephrine spray formulationsHIKMA PHARMACEUTICALS USA INC·Filed 2018·Granted Feb 7, 2023·2 cites·24 claims
- 1577US2023390218A1Epinephrine spray formulationsHIKMA PHARMACEUTICALS USA INC·Filed 2023·Application pending·0 cites
- 1676US10265309B2Sublingual opioid formulations containing naloxoneINSYS DEV CO INC·Filed 2017·Granted Apr 23, 2019·1 cites·2 claims
- 1774US2025017875A1Stable cannabinoid formulationsVANGARA KIRAN KUMAR·Filed 2024·Application pending·0 cites
- 1873US2022184215A1Stable cannabinoid formulationsRADIUS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1972US2022125932A1Stable cannabinoid formulationsRADIUS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2070US11771663B2Epinephrine spray formulationsHIKMA PHARMACEUTICALS USA INC·Filed 2021·Granted Oct 3, 2023·0 cites·16 claims
- 2170US10966925B2Epinephrine spray formulationsINSYS DEV CO INC·Filed 2019·Granted Apr 6, 2021·0 cites·10 claims
- 2270US2021330797A1Stable cannabinoid formulationsRADIUS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2368US11517525B2Epinephrine spray formulationsHIKMA PHARMACEUTICALS USA INC·Filed 2018·Granted Dec 6, 2022·0 cites·16 claims
- 2468US10617637B2Epinephrine spray formulationsHIKMA PHARMACEUTICALS USA INC·Filed 2018·Granted Apr 14, 2020·0 cites·14 claims
- 2565US2022280446A1Stable cannabinoid formulationsRADIUS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2664US10973781B2Epinephrine spray formulationsHIKMA PHARMACEUTICALS USA INC·Filed 2019·Granted Apr 13, 2021·0 cites·4 claims
- 2764US2022054450A1Stable cannabinoid formulationsRADIUS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2863US10874658B2Sublingual opioid formulations containing naloxoneINSYS DEV CO INC·Filed 2019·Granted Dec 29, 2020·0 cites·16 claims
- 2961US11911361B2Stable cannabinoid formulationsRADIUS PHARMACEUTICALS INC·Filed 2017·Granted Feb 27, 2024·0 cites·9 claims
- 3052US2016367496A1Stable cannabinoid formulationsINSYS DEV CO INC·Filed 2016·Application pending·0 cites
- 3143US2017079907A1Sublingual Epinephrine SprayINSYS DEV CO INC·Filed 2016·Application pending·0 cites
- 3242US2016199294A1Sublingual naloxone sprayINSYS DEV CO INC·Filed 2016·Application pending·0 cites
- 3341US2016271252A1Stable cannabinoid formulationsINSYS DEV CO INC·Filed 2016·Application pending·0 cites
- 3440US2017340557A1Sublingual fentanyl formulations containing a permeation enhancerINSYS DEV CO INC·Filed 2017·Application pending·0 cites
- 3539US2016296498A1Ketorolac Sublingual Spray FormulationsINSYS DEV CO INC·Filed 2016·Application pending·0 cites
- 3637US10227298B2Solid forms of a pharmaceutically active compoundHOFFMANN LA ROCHE·Filed 2015·Granted Mar 12, 2019·0 cites·12 claims
- 3734US9855234B2Diclofenac sublingual sprayINSYS PHARMA INC·Filed 2015·Granted Jan 2, 2018·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Ningxin Yan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →